Lantheus Holdings, Inc Stock Prediction
AI-powered sentiment analysis and prediction trends for LNTH, updated each market day.
LNTH AI Sentiment
AI sees no strong directional signal for Lantheus Holdings, Inc stock over the next 10 market days.
Prediction date: Sept. 21, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Lantheus Holdings, Inc
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Sector
Exchange
Market Cap
$6,582,227,400
Cap Tier
Employees
1,193
Headquarters
NORTH BILLERICA, MA
Listed Since
June 25, 2015
Website
LNTH Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
LNTH Volatility
Lantheus Holdings, Inc has shown low price volatility over the last 5 trading days. Low volatility suggests steady price action with smaller daily moves.
